News

AIBN Researchers and US company LanzaTech have developed a computer model that harnesses ancient biology for carbon-capture biotechnology. 

Professor Lianzhou Wang teamed up with researchers in academia and industry to develop printed flexible batteries.

Drugs disguised as viruses are providing new weapons in the battle against cancer, promising greater accuracy and fewer side effects than chemotherapy

A new research study is looking to improve the lives of people with diabetes by developing a matchstick-size nano-implant that removes the need for daily insulin injections.

A researcher from The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has received a joint appointment as the leader of a new initiative of CSIRO.

Start-up company Scaled Biolabs Inc is changing the way researchers around the world conduct manual cellular experiments and accelerating discoveries in biology by providing novel devices that enable 1000’s of experiments to occur simultaneously.

Patients at risk of life-threatening infections following chemotherapy could benefit from a new cell-based treatment developed from University of Queensland research.

The University of Queensland’s Australian Institute for Bioengineering and Nanotechnologywill host leading scientists from across the world at the International Conference on BioNano Innovation (ICBNI) in September next year.

New research findings from The University of Queensland have revealed that hollow nanospheres made from iron oxide hold promise as an antibacterial agent to fight diseases caused by microbial infections.

A University of Queensland (UQ) researcher has been awarded one of Australia’s highest science honours for his achievements in a career that spans rocket technology to biomedical engineering.

The University of Queensland today launched a new $7 million regenerative medicine research centre to improve older Australians’ quality of life and increase their participation and productivity.

Researchers at The University of Queensland are developing a vaccine to reduce the staggering level of infant mortality from rotavirus in developing countries by significantly decreasing the cost of vaccine production and logistics.

Queensland’s peak industry body for women in technology and life sciences has recognised the outstanding early career achievements of a young researcher from The University of Queensland.

The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology has opened the doors to a new dedicated workspace with an attached children’s play area.

The work of two Australian Institute for Bioengineering and Nanotechnology researchers was recognised at last night’s (13 July) National Health and Medical Research Council Research Excellence Awards.

A $10 million biopharmaceutical initiative with strong industry support will be established at The University of Queensland to train the next generation of scientists and enhance Australia’s capabilities in the pharmaceutical sector.

New research is striving to develop a next generation vaccine delivery platform, capable of providing immunogenic responses in a single dose using novel biomaterials.

Queensland researchers have discovered that the first-stage response of the immune system can contribute to melanoma, colon and breast cancer growth, rather than helping the body to fight it.

A recent PhD graduate from the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland has seen her research recognised with multiple successes.

Leading American biotechnology company Amyris, Inc. and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland have signed a Memorandum of Understanding to support the development of a Queensland-based biotechnology industry using feedstock from local sugarcane.